ReviewPatients With Coronary Artery Disease Unsuitable for Revascularization: Definition, General Principles, and a Classification
Section snippets
Rationale for a Classification System
The need for a classification system is supported by several reasons. Epidemiologically, more restrictive phenotypes will allow for refinement of the data available for each patient subset and help to actually constitute an identifiable population of people who are unsuitable for revascularization and living with RFA. Precise estimates of the prevalence of RFA are not available,3 leading to the potential for gross over- or underestimation of an affected population.4, 5 Likewise, there is
Definition of CAD unsuitable for revascularization
In order to propose specific phenotypes, we first offer the following operational definition of CAD unsuitable for coronary revascularization: A patient is deemed unsuitable for revascularization in the presence of a CAD due to 1 or several significant epicardial stenoses and/or to microvascular dysfunction where PCI or bypass surgery cannot be reasonably attempted or is not expected to improve myocardial perfusion. When appropriate, the diagnosis of coronary disease unsuitable for
Limitations of the Classification
The present phenotypic classification scheme relies exclusively on anatomical features identified on coronary angiogram. It does not take into account other clinical factors that can affect the decision to proceed with revascularization. Nonanatomical factors such as comorbidities, available local expertise, or procedural risk have been intentionally left out of the classification because they are difficult to capture, subject to personal interpretation, and affected ethnic origin. Clinically,
Conclusions
The heterogeneity of epidemiological data in RFA reflects the need for the phenotypic classification system proposed in this report. This classification system is simple but requires validation and endorsement by a scientific society before being used by clinicians and investigators. We believe that it can serve as a starting point toward a more precise understanding of the natural history of patients with RFA. Our classification may also pave the way to more comprehensive and appropriate
Funding Sources
Publication and distribution of this article are supported by Servier Canada and the Heart and Stroke Foundation of Ontario.
Disclosures
The authors have no conflicts of interest to disclose.
References (82)
- et al.
Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelines
Can J Cardiol
(2012) - et al.
Enhanced external counterpulsation for ischemic heart disease: what's behind the curtain?
J Am Coll Cardiol
(2003) - et al.
Clinical and research issues regarding chronic advanced coronary artery disease: part I: contemporary and emerging therapies
Am Heart J
(2008) - et al.
Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial
Lancet
(2000) - et al.
Advanced coronary artery disease: appropriate end points for trials of novel therapies
Am Heart J
(2001) - et al.
Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris: clinical results from The Norwegian Randomized Trial
J Am Coll Cardiol
(2000) - et al.
Transmyocardial laser revascularization in the patient with unmanageable unstable angina
Ann Thorac Surg
(1999) - et al.
High risk coronary artery bypass patient: incidence, surgical strategies, and results
Ann Thorac Surg
(2004) - et al.
Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current “stent era” of coronary interventions (from the ACC-National Cardiovascular Data Registry)
Am J Cardiol
(2003) - et al.
Clinical and research issues regarding chronic advanced coronary artery disease part II: trial design, outcomes, and regulatory issues
Am Heart J
(2008)
Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study
J Am Coll Cardiol
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease eventsTask Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management
J Am Coll Cardiol
Direct myocardial revascularization and angiogenesis–how many patients might be eligible?
Am J Cardiol
Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriogramsComparison with patients having significant coronary artery disease
Am J Cardiol
The anginal syndrome associated with normal coronary arteriogramsReport of a six year experience
Am J Med
“Microvascular angina” as a cause of chest pain with angiographically normal coronary arteries
Am J Cardiol
Cardiovascular outcome of patients with abnormal coronary vasomotion and normal coronary arteriography is worse in type 2 diabetes mellitus than in arterial hypertension: a 10 year follow-up study
Atherosclerosis
Coronary artery disease in the Hurler syndromeQualitative and quantitative analysis of the extent of coronary narrowing at necropsy in six children
Am J Cardiol
Cardiac involvement in inherited disorders of metabolism
Prog Cardiovasc Dis
Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent
JACC Cardiovasc Interv
Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents
JACC Cardiovasc Interv
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
Lancet
Is reoperation still a risk factor in coronary artery bypass surgery?
Ann Thorac Surg
Patencies of 2127 arterial to coronary conduits over 15 years
Ann Thorac Surg
Influence of patient characteristics and arterial grafts on freedom from coronary reoperation
J Thorac Cardiovasc Surg
Off-pump reoperative coronary artery bypass grafting by thoracotomy: patient selection and operative technique
Ann Thorac Surg
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography
J Am Coll Cardiol
Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel
JACC Cardiovasc Interv
10-year follow-up of a prospective randomized trial comparing bare-metal stenting with internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis the SIMA (Stenting versus Internal Mammary Artery grafting) trial
J Am Coll Cardiol
Are Asian coronary arteries smaller than Caucasian?A study on angiographic coronary artery size estimation during life
Int J Cardiol
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trialInvestigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME)
J Am Coll Cardiol
Percutaneous coronary intervention versus coronary bypass graft surgery for diabetic patients with unstable angina and risk factors for adverse outcomes with bypass: outcome of diabetic patients in the AWESOME randomized trial and registry
J Am Coll Cardiol
Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999
J Thorac Cardiovasc Surg
Angiographic quantification of diffuse coronary artery disease: reliability and prognostic value for bypass operations
J Thorac Cardiovasc Surg
Nonrevascularizable coronary artery disease following coronary artery bypass graft surgery: a population-based study in Olmsted County, Minnesota
Coron Artery Dis
Refractory myocardial angina and determinants of prognosis
Catheter Cardiovasc Interv
Evolving treatment strategies for chronic refractory angina
Expert Opin Pharmacother
Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease
N Engl J Med
Natural history of patients with refractory angina [abstract]
J Am Coll Cardiol
Refractory angina is associated with excessive chest pain but not excessive cardiac mortality [abstract]
J Am Coll Cardiol
A first-in-man study of percutaneous myocardial cryotreatment in nonrevascularizable patients with refractory angina
Catheter Cardiovasc Interv
Cited by (0)
See page S57 for disclosure information.